Cansino Biologics Inc Logo : 34 06 34 85 Cansino Biologics Inc - Cansino biologics, often abbreviated as cansinobio, is a chinese vaccine company.
Cansino Biologics Inc Logo : 34 06 34 85 Cansino Biologics Inc - Cansino biologics, often abbreviated as cansinobio, is a chinese vaccine company.. Cansino biologics was founded in 2009 in tianjin by yu xuefeng, zhu tao, qiu dongxu and helen mao huihua. Engages in the research and development, manufacture, and sale of vaccines. Cansino biologics inc has 1 trademark applications. Trademark applications and grants for cansino biologics inc. Cansino biologics 2009 жылы құрылған тяньцзинь ю сюэфэн, чжу тао, цю дун сю және хелен мао хуихуа.1.
Engages in the research and development, manufacture, and sale of vaccines. Its products are mainly used. When they do, their tweets will show up here. Engages in the research and development, manufacture, and sale of vaccines. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Cansino biologics inc has 1 trademark applications. Компания cansino biologics была основана в 2009 году в тяньцзине юй сюэфэном, чжу тао, цю дунсю и хелен мао хуэйхуа. Engages in the research and development, manufacture, and sale of vaccines. Is an emerging biotechnology company dedicated to vaccine research, development and commercialization. Develops, manufactures, and commercializes vaccines in the people's republic of china. Cansino biologics was founded in 2009 in tianjin by yu xuefeng, zhu tao, qiu dongxu and helen mao huihua. In july 2018, it filed an application to list on the hong kong stock exchange. Develops, manufactures, and commercializes vaccines in the people's republic of china.
Develops, manufactures, and commercializes vaccines in the people's republic of china.
When they do, their tweets will show up here. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. Develops, manufactures, and commercializes vaccines in the people's republic of china. It offers shingles, meningitis, polio, adenovirous, and tuberculosis vaccines. Its products are mainly used. Cansino biologics inc has 1 trademark applications. See insights on cansino biologics including office locations, competitors, revenue, financials, executives, subsidiaries and more at craft. Engages in the research and development, manufacture, and sale of vaccines. In july 2018, it filed an application to list on the hong kong stock exchange. 6185 | complete cansino biologics inc. Develops and manufactures biological vaccine products. Cansino biologics was founded in 2009 in tianjin by yu xuefeng, zhu tao, qiu dongxu and helen mao huihua.
Is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. Cansino biologics has 166,741 employees across 3 locations and $75.97 m in total funding,. Cansino biologics' shares rose 380% in 2020. It offers shingles, meningitis, polio, adenovirous, and tuberculosis vaccines. 6185 | complete cansino biologics inc.
It offers shingles, meningitis, polio, adenovirous, and tuberculosis vaccines. Cansino biologics, often abbreviated as cansinobio, is a chinese vaccine company. Develops and manufactures biological vaccine products. It offers shingles, meningitis, polio, adenovirous, and tuberculosis vaccines. Is a vaccine manufacturing facility. In july 2018, it filed an application to list on the hong kong stock exchange. Engages in the research and development, manufacture, and sale of vaccines. Develops, manufactures, and commercializes vaccines in the people's republic of china.
Engages in the research and development, manufacture, and sale of vaccines.
Engages in the research and development, manufacture, and sale of vaccines. Develops, manufactures, and commercializes vaccines in the people's republic of china. (cansinobio, stock 6185.hk) is a biopharmaceutical company dedicated to exploring the prevention of diseases through research & development, advanced manufacturing and commercialization of vaccine products for human use worldwide. Is an emerging biotechnology company dedicated to vaccine research, development and commercialization. Cansino biologics, often abbreviated as cansinobio, is a chinese vaccine company. Its products are mainly used. Its products are mainly used. Cansino biologics inc has 1 trademark applications. In july 2018, it filed an application to list on the hong kong stock exchange. It offers shingles, meningitis, polio, adenovirous, and tuberculosis vaccines. Cansino biologics was founded in 2009 in tianjin by yu xuefeng, zhu tao, qiu dongxu and helen mao huihua. Is a vaccine manufacturing facility. Cansino biologics was founded in 2009 in tianjin by yu xuefeng, zhu tao, qiu dongxu and helen mao huihua.
In july 2018, it filed an application to list on the hong kong stock exchange. Its products are mainly used. Cansino biologics was founded in 2009 in tianjin by yu xuefeng, zhu tao, qiu dongxu and helen mao huihua. A logo of china's vaccine specialist cansino biologics inc is pictured in tianjin, china aug 17, 2020. Develops, manufactures, and commercializes vaccines in the people's republic of china.
(cansinobio, stock 6185.hk) is a biopharmaceutical company dedicated to exploring the prevention of diseases through research & development, advanced manufacturing and commercialization of vaccine products for human use worldwide. Cansino biologics 2009 жылы құрылған тяньцзинь ю сюэфэн, чжу тао, цю дун сю және хелен мао хуихуа.1. Компания cansino biologics была основана в 2009 году в тяньцзине юй сюэфэном, чжу тао, цю дунсю и хелен мао хуэйхуа. Its products are mainly used. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 6185 | complete cansino biologics inc. Is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. A logo of china's vaccine specialist cansino biologics inc is pictured in tianjin, china aug 17, 2020.
The latest application filed is for menhycia.
A logo of china's vaccine specialist cansino biologics inc is pictured in tianjin, china aug 17, 2020. Is an innovative biopharmaceutical company dedicated to exploring best solutions to the prevention of diseases through cutting edge research & development, advanced manufacturing and commercialization of innovative vaccine products for human use worldwide. (cansinobio, stock 6185.hk) is a biopharmaceutical company dedicated to exploring the prevention of diseases through research & development, advanced manufacturing and commercialization of vaccine products for human use worldwide. Engages in the research and development, manufacture, and sale of vaccines. Cansino biologics, often abbreviated as cansinobio, is a chinese vaccine company. Cansino biologics was founded in 2009 in tianjin by yu xuefeng, zhu tao, qiu dongxu and helen mao huihua. It offers shingles, meningitis, polio, adenovirous, and tuberculosis vaccines. When they do, their tweets will show up here. Is a vaccine manufacturing facility. Cansino biologics, often abbreviated as cansinobio, is a chinese vaccine company. Its products are mainly used. It offers shingles, meningitis, polio, adenovirous, and tuberculosis vaccines. Its products are mainly used.